COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1

Historical Holders from Q2 2021 to Q2 2025

Type / Class
Debt / NOTE 1.500% 4/1
All holders as of 30 Jun 2025
Q2 2025
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-12
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1

Period Principal Value Change Price Investors
2025 Q2 0 $0 -$199,168,381 0
2025 Q1 144,739,249 $199,168,381 +$10,151,140 $0.9795 12
2024 Q4 137,699,979 $187,201,296 +$172,568 $0.97 17
2024 Q3 154,545,602 $121,262,001 +$954,484 $0.785 22
2024 Q2 156,533,812 $140,568,054 -$17,205,821 $0.735 25
2024 Q1 181,571,812 $140,461,793 -$6,883,576,128 $0.6411 24
2023 Q4 211,845,000 $122,230,738 +$6,224,860 $0.5672 27
2023 Q3 199,445,755 $122,375,975 -$6,439,666 $0.6125 22
2023 Q2 209,844,000 $132,818,459 -$6,673,832 $0.6185 24
2023 Q1 218,350,500 $155,131,944 -$47,005 $0.7028 28
2022 Q4 218,899,500 $145,364,935 -$2,270,074 $0.6575 29
2022 Q3 216,906,500 $172,535,541 +$28,191,315 $0.7913 28
2022 Q2 186,825,000 $122,124,320 +$1,758,183 $0.6532 24
2022 Q1 166,304,000 $163,025,279 -$4,675,525 $0.9929 22
2021 Q4 167,332,000 $185,926,528 -$24,706,873 $1.11 23
2021 Q3 189,572,000 $209,789,973 +$18,768,511 $1.11 26
2021 Q2 172,807,000 $177,229,715 +$177,229,715 $1.02 25